Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Clinical Translational Researcher

Oncology · Vietnam · 2025-04-24

Processing Time
139 days
Decision Date
2025-04-24
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance personalized oncology by integrating multi-omics analysis for biomarker discovery and population pharmacokinetic modeling to optimize cancer therapy. His work focuses on implementing model-informed precision dosing strategies and translating these innovations into real-world clinical settings to improve patient-centered therapeutic interventions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical healthcare priorities in the U.S. through precision oncology and biomarker discovery.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to his M.D., Ph.D., and extensive experience in both clinical practice and translational research.

3 Balance of Interests Met

On balance, the petitioner's unique ability to translate complex modeling into patient care makes a waiver of the labor certification beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.D. and Ph.D. degrees and his record of 6 peer-reviewed journal articles which accumulated 203 citations. Evidence included 4 papers ranked in the top 10-20% of most-cited articles in Clinical Medicine and proof of competitive international research funding. His dual background in clinical practice and research positioned him to satisfy the Dhanasar prongs.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE questioning aspects of the petitioner's eligibility, which was addressed by a strategic response highlighting the significance of his research and clinical leadership.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Doctor

Healthcare · China

WeGreened EB-2 (NIW) rfe approved
169 days 2025-06-11
The petitioner proposes to continue his work in personalized oncology by developing tailored treatment regimens based on molecular diagnostics and tumor genomics. His research focuses on refining patient stratification to enable more effective and less toxic cancer therapies.
View Case

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Statistician

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Georgia 8 days 2023-07-18
The petitioner proposes to advance statistical models for drug development and clinical trial methodologies to improve cancer prognosis and treatment outcomes. His work focuses on time-to-event data analysis to enhance the accurate prediction of patient outcomes, risk stratification, and the optimization of clinical trial designs within the pharmaceutical industry.
View Case

Assistant Professor

Healthcare · Lebanon

WeGreened EB-2 (NIW) approved
New York 283 days 2025-02-14
The petitioner proposes to continue his clinical research in precision oncology and immune profiling, focusing on the use of biomarkers to improve the diagnosis and treatment of complex cancers such as renal cell carcinoma and multiple myeloma. His work involves the development and validation of novel imaging and staining techniques to better understand immune microenvironments and treatment responses.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Vietnam

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 139 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Vietnam All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist